CLN supplement 2020-12-Univants_hr

The team analyzed laboratory spends in the emergency department (ED) during the COVID-19 cardiac troponin results, clinical risk, and final patient outcomes pandemic, to identifying kidney disease in indigenous communi- to determine if it was possible to design and subsequently imple- ties early enough to slow the progression of disease, to reducing ment a new pathway for patient care that could r. [...] “Waiting for and then actioning New Chest Pain Pathway the results of the second cardiac troponin test really takes time, Patients with chest pain and other symptoms of a possible heart and they often are moved somewhere else in the hospital, which attack have historically represented the most common cause of potentially increases their risk of exposure to the [SARS-CoV-2] hospital admissions in N. [...] A year and treatment, and improved monitoring a half since the initial screening, 90% of to minimize costs of diabetes-related CLN-Supplement_Nov 2020.indd 4 11/16/20 4:48 PM DECEMBER 2020 • SPECIAL SUPPLEMENT 5 complications n and improve quality of Between 2016 and 2019, the number life, the Hospital Universitari Sant Joan of patients with HbA1c under 8% d’Alacant in Alicante, Spain, in 2016 imp. [...] “In events related to failure in the manage- ensured that the laboratory information addition, we created a code H application, ment of patients with severe hemorrhagic systems (LIS) of the private labs were which guides the protocol step-by-step diseases; and payers are, at the end of the interfaced with the DHA LIS, which in with algorithms and flowcharts developed day, happy.” turn was integrat. [...] This offered the public health lab team was directly involved with both UNIVANTS finalist with distinction system the data it needed for prompt the coordination and validation of the and received the highest award scores for contact tracing and isolation of infected point-of-care testing and with the develop- the Latin America and Caribbean region.